Lundbeck Inc. (formerly Ovation Pharmaceuticals) Q1 Beats Forecasts, Cuts Profit Outlook

Bookmark and Share

Reuters -- Danish pharmaceutical group Lundbeck posted a surprise rise in first-quarter operating profit on Wednesday as sales of its antidepressant Cipralex boosted revenues, sending its shares up.

MORE ON THIS TOPIC